To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Hirva Mamdani, M.D. , leader of the Thoracic Oncology Multidisciplinary Team and member of the Phase I Clinical-Pharmacology Program ; Hadeel Assad, M.D. , medical oncologist and member of the Breast Cancer Multidisciplinary Team and Phase I Clinical-Pharmacology Program; and Natasha Robinette, M.D. , clinical service chief of imaging and member of the Head and Neck Oncology , Melanoma , Multiple Myeloma and Amyloidosis and Neuro-Oncology Multidisciplinary Teams at Barbara Ann Karmanos Cance...
"This moment was a moment of humility, honor, hope, celebration and encouragement.” Barbara Ann Karmanos Institute’s 10 th Annual Pink Out the Park event was a successful hit out of the ballpark. Under the bright lights of Comerica Park, hundreds of breast cancer survivors decked out in pink took to the baseball diamond to be recognized in a special pre-game ceremony. The Pink Out the Park game on Friday, May 13, held in partnership with the Detroit Tigers, Karmanos Cancer Institute and McLaren Health C...
OncLive In this article, four leading breast cancer specialists at Barbara Ann Karmanos Cancer Institute talk about treatments and clinical trials for breast cancer. Hadeel Assad, M.D. , medical oncologist and member of the Breast Cancer and Phase I Clinical-Pharmacology Multidisciplinary Teams at the Karmanos Cancer Institute, discussed how CDK4/6 inhibitors have been implemented into practice, as well as updates on HER2-positive breast cancer and triple-negative breast cancer clinical trials. Lawrence...